The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer
Official Title: Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer
Study ID: NCT02075385
Brief Summary: General Objective: To evaluate the swallowing results of speech pathologist rehabilitation of advanced oropharynges, larynx and hypopharynx cancer patients during neoadjuvant chemotherapy and radiotherapy concomitant to chemotherapy. Methods and Casuistic: Randomized clinical trial phase II. 80 patients with advanced oropharynges, larynx and hypopharynx cancer diagnoses from Barretos Cancer Hospital, which had the proposal of neoadjuvant chemotherapy followed by radiotherapy combined with chemotherapy. Patients are randomized on two groups: control group and speech pathology therapy group
Detailed Description: To evaluate and compare the swallowing and life quality swallowing on a group undergoing to speech pathology therapy (intervention) and a control group (no intervention).
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Barretos Cancer Hospital, Barretos, São Paulo, Brazil
Name: André L Carvalho, PHD
Affiliation: Fundação Pio XII - Hospital de Câncer de Barretos
Role: STUDY_CHAIR
Name: Luciano S Viana, PHD
Affiliation: Fundação Pio XII - Hospital de Câncer de Barretos
Role: STUDY_DIRECTOR
Name: Alexandre Jacinto, MD
Affiliation: Fundação Pio XII - Hospital de Câncer de Barretos
Role: STUDY_DIRECTOR
Name: Juliana Portas, MSC
Affiliation: Fundação Pio XII - Hospital de Câncer de Barretos
Role: PRINCIPAL_INVESTIGATOR